Limpar
76.246 resultados

Acesso aberto

Tipo do recurso

Tipo de base de dados

Ano de criação

Produção nacional

Revisado por pares

Áreas

Idioma

Editores

Livro

Alexander Street

Artigo Acesso aberto Revisado por pares

Michael H. Tomasson, Shinsuke Iida, Rubén Niesvizky, Mohamad Mohty, Nizar J. Bahlis, Joaquín Martínez‐López, Guenther Koehne, Paula Rodríguez‐Otero, H. Miles Prince, Andrea Viqueira, Eric Leip, Umberto Conte, Sharon T. Sullivan, Alexander M. Lesokhin,

... advisory roles for Janssen. Shinsuke Iida: honoraria from Bristol Myers Squibb, Celgene, Janssen, Pfizer, Sanofi, and Takeda; ... and Takeda; and research funding from AbbVie, Amgen, Bristol Myers Squibb, Caelum Biosciences, Celgene, Daiichi Sankyo, Janssen, ... Takeda. Ruben Niesvizky: consulting or advisory roles for Bristol Myers Squibb, GSK, Janssen, Karyopharm Therapeutics, and Takeda and research funding from Bristol Myers Squibb, GSK, Janssen, Karyopharm Therapeutics, and Takeda. ... Sanofi, and Xenikos; personal fees from Amgen, Astellas, Bristol Myers Squibb, Celgene, Pfizer, Stemline-Menarini and Takeda; ...

Tópico(s): HIV/AIDS drug development and treatment

2024 - Wolters Kluwer | HemaSphere

Periodico Acesso aberto

PubMed Central (PMC)

Primary Document -- Manuscript Acesso aberto

Leaflet: Copy of letter from Bristol to National Committee. Bristol Belgian Refugees. Belgium. 19 Apr. 1915. BEL 6 28/3. Book.

1915 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Jensen Yeung, Melinda Gooderham, Hung Hong, Charles Lynde, Vimal H. Prajapati, Perla Lansang, Irina Turchin, Marni Wiseman, Carolyn Jack, Michele Ramien, Kerri Purdy, Parbeer Grewal,

... Allergan, Amgen, Arcutis, Astellas, Bausch Health, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Centocor, Coherus, Dermavant, Dermira, Forward, ... AbbVie, Amgen, Akros, Arcutis, Bausch Health, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Dermira, Dermavant, Eli Lilly, Galderma, ... services from AbbVie, Akros, Amgen, Arcutis, Boehringer-Ingelheim, Bristol-Myers Squibb, Celgene, Cutanea, Dermira, Dermavant, DS Biopharma, ... Amgen, Aralez, Arcutis, Bausch Health, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Cipher, Dermavant, Eli Lilly, Fresnius ...

Tópico(s): Asthma and respiratory diseases

2023 - Elsevier BV | Journal of the American Academy of Dermatology

Primary Document -- Manuscript Acesso aberto

Newspaper cuttings: Belgian Refugees Arrive In Bristol: An Enthusiastic Welcome. Bristol Belgian Refugees. Belgium. 1914. BEL 6 28/11. Book.

1914 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Franck Morschhauser, Saurabh Dahiya, M. Lia Palomba, Alejandro Martı́n, Juan Luis Reguera Ortega, John Kuruvilla, Ulrich Jäger, Guillaume Cartron, Koji Izutsu, Martin Dreyling, Brad S. Kahl, Hervé Ghesquières, Kirit M. Ardeshna, Hideki Goto, Anna Maria Barbui, Jeremy S. Abramson, Peter Borchmann, Isabelle Fleury, Stephan Mielke, Thalia A. Farazi, Omotayo Fasan, James Lymp, Min Vedal, Ryuichi Nishii, Ariel Avilion, J. Papuga, Loretta J. Nastoupil,

... by: This study was funded by Celgene, a Bristol-Myers Squibb Company. All authors contributed to and ... The Lockwood Group (Stamford, CT, USA), funded by Bristol Myers Squibb. Keyword: Indolent non-Hodgkin lymphoma Conflicts ... role Otsuka, Kyowa Kirin, Genmab, Tanabe Mitsubishi Honoraria: Bristol Myers Squibb, AstraZeneca, Eisai Zenyaku, Kyowa Kirin, Takeda, ... spouse): ScientifyResearch T. Farazi Employment or leadership position: Bristol Myers Squibb Stock ownership: Bristol Myers Squibb Other remuneration: Patents: Bristol Myers Squibb ...

Tópico(s): Lymphoma Diagnosis and Treatment

2023 - Wiley | Hematological Oncology

Primary Document -- Manuscript Acesso aberto

Press cuttings: Belgian Refugees In Bristol. Bristol. Local Records. L.R. 65/10. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Anjali Owens, Ahmad Masri, Theodore P. Abraham, Lubna Choudhury, Florian Rader, John D. Symanski, Aslan T. Turer, Timothy C. Wong, Albree Tower‐Rader, Caroline Coats, Michael A. Fifer, Iacopo Olivotto, Scott D. Solomon, Hugh Watkins, Stephen B. Heitner, Daniel Jacoby, Stuart Kupfer, Fady I. Malik, Lisa Meng, Regina Sohn, Amy Wohltman, Martin S. Maron,

... pi/pi_camzyos.pdf (accessed June 9 2023). Bristol-Myers Squibb Company, Princeton, NJ, USA.Google Scholar ... Owens has received consultant/advisor fees from Cytokinetics, Bristol Myers Squibb/MyoKardia, and Pfizer. Dr Masri has received consultant/advisor fees from Tenaya, Attralus, Cytokinetics, Bristol Myers Squibb, Eidos, Pfizer, Alnylam, Haya, Intellia and ... Dr Rader has received speaker bureau fees from Bristol Myers Squibb and Medtronic, and consultant/advisor fees from Bristol Myers Squibb, Cytokinetics, ReCor, and Medtronic. Dr Symanski ...

Tópico(s): Williams Syndrome Research

2023 - Elsevier BV | Journal of Cardiac Failure

Primary Document -- Manuscript Acesso aberto

Press cuttings: Bristol's Chocolate Day. Bristol. Local Records. L.R. 65/14. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Michael Wang, Tanya Siddiqi, Leo I. Gordon, Manali Kamdar, Matthew A. Lunning, Alexandre V. Hirayama, Jeremy S. Abramson, Jon Arnason, Nilanjan Ghosh, Amitkumar Mehta, Charalambos Andreadis, Scott R. Solomon, Ana Kostić, C. Dehner, Ricardo Espinola, Lily Peng, K. OGASAWARA, Amy M. Chattin, M. Lia Palomba,

... This study was funded by Juno Therapeutics, a Bristol-Myers Squibb Company. All authors contributed to and ... The Lockwood Group (Stamford, CT, USA), funded by Bristol Myers Squibb. Keyword: Cellular therapies Conflicts of interests ... AbbVie, Acerta Pharma, AstraZeneca, Bantam Pharmaceutical, BeiGene, BioInvent, Bristol Myers Squibb, CAHON, Dava Oncology, Eastern Virginia Medical ... Biotechnologies, Abbvie, BeiGene, ADC Therapeutics, Syncopation Life Sciences, Bristol-Myers Squibb/Celgene, Genetech/Roche, Seattle Genetics Research ...

Tópico(s): Biomedical Ethics and Regulation

2023 - Wiley | Hematological Oncology

Primary Document -- Manuscript Acesso aberto

Article from The World 'Bristol's Uncle Jack. Bristol. Local Records. L.R. 65/68. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Richard B. Warren, A. Armstrong, M. Gooderham, B. Strober, D. Thaçi, S. Imafuku, H. Sofen, L. Spelman, N. J. Korman, M. Zheng, E. Colston, J. Throup, S. Kundu, R. Kisa, S. Banerjee, A. Blauvelt,

... deucravacitinib treatment. Acknowledgements This study was sponsored by Bristol Myers Squibb. Professional medical writing assistance was provided ... Health company, Parsippany, NJ, USA, and funded by Bristol Myers Squibb. Disclosure of Interests Richard B. Warren ... research support from: Grants and personal fees: AbbVie, Bristol Myers Squibb, Eli Lilly, Janssen, Leo Pharma, and ... Novartis, Sanofi Genzyme, and Valeant; Principal investigator: Aslan, Bristol Myers Squibb, Dermavant, Dermira, GlaxoSmithKline, MedImmune, Merck, Roche ...

Tópico(s): Mast cells and histamine

2022 - BMJ | Annals of the Rheumatic Diseases

Primary Document -- Manuscript Acesso aberto

Newspaper cuttings: The Bristol Observer Toy Scheme. Bristol. Local Records. L.R. 65/30. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

E. Morand, Margaret N. Pike, JT Merrill, Ronald van Vollenhoven, V. P. Werth, Coburn Hobar, Nikolay Delev, V. Shah, Brian J. Sharkey, T. Wegman, Ian M. Catlett, Sibabrata Banerjee, Shalabh Singhal,

... 3 trials. Acknowledgements This study was sponsored by Bristol Myers Squibb. Professional medical writing assistance was provided ... Health company, Parsippany, NJ, USA, and funded by Bristol Myers Squibb. The authors acknowledge Christina Crater, MD, who was employed by Bristol Myers Squibb at the time the study was ... Disclosure of Interests Eric Morand Consultant of: AstraZeneca, Bristol Myers Squibb, Biogen, Eli Lilly, EMD Serono, Genentech, ... Novartis , Grant/research support from: AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Biogen, Eli Lilly, EMD Serono, Genentech, ...

Tópico(s): Systemic Lupus Erythematosus Research

2022 - BMJ | Annals of the Rheumatic Diseases

Primary Document -- Manuscript Acesso aberto

Note in shorthand, Bristol 3. Bristol. Local Records. L.R. 65/29. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Matthew J. Akiyama, Lindsey Riback, Mercy Nyakowa, Helgar Musyoki, John Lizcano, Abbe Muller, Chenshu Zhang, Josephine G. Walker, Jack Stone, Peter Vickerman, Peter Cherutich, Ann Kurth,

... authorJosephine G. Walker, Josephine G. Walker University of Bristol, Bristol, UKSearch for more papers by this authorJack Stone, Jack Stone University of Bristol, Bristol, UKSearch for more papers by this authorPeter Vickerman, ... orcid.org/0000-0002-8291-5890 University of Bristol, Bristol, UKSearch for more papers by this authorPeter Cherutich, ... authorJosephine G. Walker, Josephine G. Walker University of Bristol, Bristol, UKSearch for more papers by this authorJack Stone, Jack Stone University of Bristol, Bristol, UKSearch for more papers by this authorPeter ...

Tópico(s): HIV, Drug Use, Sexual Risk

2022 - Wiley | Journal of Viral Hepatitis

Primary Document -- Manuscript Acesso aberto

Press cuttings: Bristol's Own. Bristol. Local Records. L.R. 65/17. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Artigo Acesso aberto Revisado por pares

Richard B. Warren, H. Sofen, S. Imafuku, J. Szepietowski, A. Blauvelt, L. Spelman, E. Colston, J. Toms, A. Buck, S. Banerjee, A. Menter,

... 25, 2021. Acknowledgements This study was sponsored by Bristol Myers Squibb. Writing and editorial assistance was provided ... OPEN Health company, Parsippany, NJ, USA, funded by Bristol Myers Squibb. Disclosure of Interests Richard B. Warren ... Consultant of: Clinical investigator: AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, Eli Lilly, Janssen, Leo Pharma, Novartis, ... Mitsubishi, and Torii Yakuhin; Personal fees: Amgen (Celgene), Bristol Myers Squibb, Daiichi Sankyo, Eli Lilly, Novartis, and ...

Tópico(s): Autoimmune Bullous Skin Diseases

2022 - BMJ | Annals of the Rheumatic Diseases

Periodico Acesso aberto

PubMed Central (PMC)

Primary Document -- Manuscript Acesso aberto

Newspaper cuttings: Bristol And The National Fund. Bristol. Local Records. L.R. 65/73. Book.

0000 - Gale Group | ArchivesUnbound Women-War

Editorial Acesso aberto Revisado por pares

Khaled M. Musallam, Alì Taher, Maria Domenica Cappellini, Olivier Hermine, Kevin H.M. Kuo, Sujit Sheth, Vip Viprakasit, John B. Porter,

... KMM reports consultancy fees from Novartis, Celgene Corp (Bristol Myers Squibb), Agios Pharmaceuticals, CRISPR Therapeutics, Vifor Pharma, ... ATT reports consultancy fees from Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma, Silence Therapeutics and Ionis Pharmaceuticals; and research funding from Novartis, Celgene Corp (Bristol Myers Squibb), La Jolla Pharmaceutical Company, Roche, Protagonist ... MDC reports consultancy fees from Novartis, Celgene Corp (Bristol Myers Squibb), Vifor Pharma and Ionis Pharmaceuticals; and ...

Tópico(s): Blood groups and transfusion

2022 - Wolters Kluwer | HemaSphere